Human NK cell development and effector functions in Health and disease

Live

The Marseille Cancer Research Center celebrates its 50th anniversary ! -

the Team publications

Sep 2019 Oncotarget

Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.

Chretien AS, Fauriat C, Orlanducci F, Rey J, Borg GB, Gautherot E, Granjeaud S, Demerle C, Hamel JF, Cerwenka A, von Strandmann EP, Ifrah N, Lacombe C, Cornillet-Lefebvre P, Delaunay J, Toubert A, Arnoulet C, Vey N, Olive D

Oct 2023 EMBO molecular medicine

Downregulation of stromal syntenin sustains AML development.

Leblanc R, Ghossoub R, Goubard A, Castellano R, Fares J, Camoin L, Audebert S, Balzano M, Bou-Tayeh B, Fauriat C, Vey N, Garciaz S, Borg JP, Collette Y, Aurrand-Lions M, David G, Zimmermann P

Nov 2021 Frontiers in immunology

Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia.

Grenier JMP, Testut C, Fauriat C, Mancini SJC, Aurrand-Lions M

See all the publications